基本信息
views: 3
Career Trajectory
Bio
Our lab is using the recently developed technique known as gene targeting to create animal models for human diseases and to identify genes that modify the progress of these diseases . The technique of gene targeting, which allows us to introduce specific changes into the genomes of experimental animals, relies on recent advances in the fields of homologous recombination and embryonic stem (ES) cell technology. The first step in this procedure, once the gene to be modified has been chosen, is to obtain corresponding genomic DNA sequences using standard cloning techniques. After introducing desired mutations into the cloned DNA using conventional molecular biology techniques, the genomic sequences are incorporated into a plasmid known as a targeting vector. When this plasmid is introduced into mouse ES cells, the altered genomic sequences are able to undergo homologous recombination with the corresponding endogenous sequences, thereby introducing the desired modifications into the mouse genome. ES cells are unique in that they can be grown in tissue culture while maintaining their totipotency. Thus, once ES cells carrying the desired mutation are identified, they can be returned to an embryo, resulting in the formation of a chimeric animal. If the embryonic stem cells participate in the formation of the germ line of the chimeric animal, the mutation will be transmitted to the chimera’s offspring, and a mouse line carrying the desired mutation will be created. The effect of this alteration can then be studied in vivo. This technology has opened an exciting new avenue for addressing numerous biological and medical problems.
Research Interests
Papers共 288 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Pamela Smolak,MyTrang Nguyen,Christine Diamond,Heather Wescott,John R. Doedens, Kenneth Schooley,John N. Snouwaert, Mark G. Bock,David Harrison,Alan P. Watt,Beverly H. Koller,Christopher A. Gabel
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSno. 3 (2024): 798-812
John R Doedens,Pamela Smolak,MyTrang Nguyen,Heather Wescott,Christine Diamond, Ken Schooley, Andy Billinton,David Harrison,Beverly H Koller,Alan P Watt,Christopher A Gabel
ACS pharmacology & translational scienceno. 5 (2024): 1438-1456
John R. Doedens,Pamela Smolak,MyTrang Nguyen,Heather Wescott,Christine Diamond, Ken Schooley, Andy Billinton,David Harrison,Beverly H. Koller,Alan P. Watt,Christopher A. Gabel
ACS Pharmacology & Translational Science (2024)
Cell reportsno. 3 (2024): 113852-113852
Antimicrobial agents and chemotherapypp.e0067124-e0067124, (2024)
ENVIRONMENTAL HEALTH PERSPECTIVESno. 12 (2023)
Gabriele Matschiner,Mary F. Fitzgerald,Ulrich Moebius,Andreas M. Hohlbaum,Hendrik Gille,Kristian Jensen, Klaus Kirchfeld,Barbara Rattenstetter, Alice Laforge,Rachida S. Bel Aiba, Joe Ciccotosto, Hong Nyugen,Martyn L. Foster,John N. Snouwaert,MyTrang Nguyen,Beverly H. Koller,Louis Matis,Gary P. Anderson,Shane A. Olwill
Environmental health perspectivesno. 12 (2023): 127021-127021
Load More
Author Statistics
#Papers: 289
#Citation: 35547
H-Index: 84
G-Index: 188
Sociability: 7
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn